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Solid organ transplant recipients can acquire Strongyloides stercoralis from an 26 
infected donor. The diagnosis of S. stercoralis in immunocompromised individuals may be 27 
challenging due to a lower sensitivity of available parasitological and serological methods, 28 
compared to immunocompetent individuals. Recently, a real-time polymerase chain 29 
reaction (RT-PCR) in stool has been developed for S. stercoralis diagnosis. We report two 30 
cases of S. stercoralis infection transmitted by a donor to two solid organ transplant 31 
recipients, who were diagnosed with RT-PCR in stool. This test could play a role in S. 32 
stercoralis diagnosis in immunosuppressed patients, facilitating rapid treatment initiation 33 
and reducing the risk of severe strongyloidiasis. Adherence to current recommendations of 34 
screening among donors and recipients from endemic areas is also urgently needed. 35 





Strongyloides stercoralis causes an opportunistic infection among 37 
immunosuppressed individuals. Chronically infected recipients of solid organ transplants 38 
(SOT) from endemic areas have an increased risk of severe strongyloidiasis, due to their 39 
immunosuppressed status.1 In recent years, some authors have reported the transmission 40 
of S. stercoralis from infected donors to recipients.2-5 Interestingly, most cases were 41 
diagnosed when recipients presented with hyperinfection syndrome and donors were found 42 
to have S. stercoralis on retrospective testing. 43 
Routine diagnosis of S. stercoralis is based on parasitological methods and serology, 44 
although their performance is far from optimal.6 Real-time polymerase chain reaction (RT-45 
PCR) has emerged as a promising diagnostic tool for S. stercoralis.7 Little is known about its 46 
potential role in subjects with a depressed cellular immune response, such as SOT 47 
recipients. 48 
We describe the usefulness and potential role of RT-PCR for the diagnosis of S. 49 
stercoralis in immunosuppressed individuals. This technique was used to detect the 50 
transmission of the parasite from an infected donor to two SOT recipients.  51 




Case report 52 
Donor 53 
A 45-year-old female patient from Paraguay was admitted to a Spanish hospital with 54 
one-month history of dyspnea, dry cough and fever. The patient had a previous diagnosis of 55 
systemic lupus erythematosus with nephropathy and she was under chronic therapy with 56 
steroids and mycophenolate mofetil. Upon admission, a chest x-ray showed bilateral 57 
alveolo-interstitial infiltrates and her blood tests revealed an acute renal failure and a non-58 
hemolytic anemia. 59 
On suspicion of a lupus flare the patient received a 500 mg methylprednisolone 60 
bolus. The patient’s respiratory condition progressively worsened, requiring admission to 61 
the intensive care unit. Piperacillin-tazobactam, levofloxacin and trimetoprim-62 
sulfametoxazol were added. Shortly after, hemoptysis developed with acute respiratory 63 
failure, prompting intubation and bronchoscopy which showed active bleeding in the left 64 
lung. An angio-CT revealed extensive peribronchovascular infiltrates suggestive of alveolar 65 
hemorrhage without malformations of bronchial arteries. An endovascular embolization of a 66 
left bronchial artery branch was performed. 67 
The patient was then treated with methylprednisolone, rituximab, mycophenolate 68 
mofetil and 4 days of immunoglobulins without clinical improvement. Broad-spectrum 69 
antibiotics were maintained. Ten days after admission, the patient developed a sudden 70 
hypertensive emergency associated with coma and non-reactive bradycardia. A brain CT 71 
revealed bilateral intracerebral hemorrhage and the patient finally died after evolving to 72 
brain death.  73 




The family consented for organ procurement and heart and liver were extracted for 74 
transplantation. Since the donor had lived in an endemic area, S. stercoralis serology was 75 
then performed using the commercial serological test IVD-ELISA (IVD Research, Carlsbad, 76 
CA), which detects IgG antibodies by using somatic antigens from S. stercoralis larvae. A 77 
positive result (i = 4.49 U/µL) was received on day 9 post-transplant. Transplant teams and 78 
organ procurement organizations were alerted.  79 
Recipient 1 80 
A 66-year old female patient with end-stage hepatic cirrhosis by hepatitis C virus 81 
infection underwent orthotopic liver transplantation. She was born and had lived in Spain 82 
during all her life. Immunosuppressive therapy was initiated with basiliximab, 83 
methylprednisolone and mycophenolate mofetil.  84 
On day 9, after receiving the positive result of S. stercoralis serology from the donor, 85 
ivermectin was empirically initiated at a dose of 200 µg/kg/day. Two stool samples were 86 
collected, but no larvae were found after direct examination. S. stercoralis serology was 87 
negative (i = 0.035 U/µl). The patient received 14 days of ivermectin and stools were 88 
monitored for larvae, which were not found on direct examination. 89 
The patient followed a severe clinical course, presenting multiple complications ten 90 
days after ending ivermectin. She was diagnosed with acute hepatitis by type 1 and 2 herpes 91 
viruses and abdominal septic shock, requiring treatment with vasopressors. She was treated 92 
with acyclovir, meropenem and vancomycin, but finally needed intravenous colistin due to 93 
multiresistant Pseudomonas aeruginosa bacteremia and bilateral pneumonia. The patient 94 
developed multiorgan failure, despite all treatment efforts, and died on day 34 post-95 
transplant. 96 




Stool samples collected prior to ivermectin initiation were sent to the National 97 
Centre for Microbiology (CNM-ISCIII), where RT-PCR for S. stercoralis was performed using 98 
the pair of primers designed from S. stercoralis 18S rRNA gene sequence.7 The amplification 99 
of the extracted DNA from previously concentrated stool samples is carried out according to 100 
the protocol described by Saugar et al.8 This test resulted positive. 101 
Recipient 2 102 
A 56-year old male patient was diagnosed with acute myocarditis and eventually 103 
cardiogenic shock that needed mechanical circulatory support with extracorporeal 104 
membrane oxygenation. Endomyocardial biopsy only showed fibrosis but with no 105 
myocardial cells. During the next month his condition did not improve and he was 106 
considered for orthotopic cardiac transplantation. He was born and had lived in Spain during 107 
all his life. After transplantation, he was initiated on immunosuppressive therapy with 108 
steroids, basiliximab, tacrolimus and mycophenolate mofetil. Pathological analysis of the 109 
recipient’s heart showed giant-cell myocarditis. 110 
On day 4 post-transplant, although he had normal cardiac and renal function, he 111 
presented with acute respiratory insufficiency requiring non-invasive mechanical 112 
ventilation. A chest x-ray revealed bilateral alveolo-interstitial infiltrates (Figure 1). Empirical 113 
antibiotic therapy with meropenem, linezolid and trimetoprim-sulfametoxazol was initiated 114 
and mycophenolate mofetil was discontinued. The patient underwent a bronchoscopy with 115 
bronchoalveolar lavage showing alveolar hemorrhage. 116 
All microbiological examinations in blood and bronchoalveolar lavage fluid were 117 
negative for bacteria, virus and fungi. Upon knowledge of donor’s positive S. stercoralis 118 
serology, on day 9 post-transplant, empirical oral treatment with ivermectin 200 µg/kg/day 119 




and albendazole 400 mg/12h was initiated and the dose of tacrolimus and steroids was 120 
decreased. The patient’s symptoms improved rapidly until complete resolution with 121 
radiologic disappearance of infiltrates. Treatment continued for 3 weeks and 122 
immunosuppressive drugs were reintroduced gradually. Two stool samples were negative 123 
for larvae on direct examination and the serology was non-reactive. The patient was finally 124 
discharged. Stool samples collected prior to ivermectin initiation were sent to CNM-ISCIII 125 
and RT-PCR tested positive for S. stercoralis. 126 





Our findings stress the importance of S. stercoralis screening among donors from 128 
endemic areas. It also highlights that RT-PCR in stools can provide an early diagnosis in those 129 
individuals receiving SOT from infected donors, prompting an early treatment and 130 
preventing the development of hyperinfection syndrome. 131 
This case adds to the existing reports of S. stercoralis transmission from donors to 132 
SOT recipients,2-5 but there are some important differences in our case. All donor-to-133 
recipients transmissions described so far were investigated when at least one SOT recipient 134 
presented with severe strongyloidiasis. Most cases were diagnosed 2-3 months after 135 
transplantation,2 probably after a sufficient period of immunosuppressive therapy. 136 
However, in our case, the donor was diagnosed post-mortem with a positive serology, which 137 
prompted investigations and empirical treatment of SOT recipients. One could even 138 
hypothesize that the donor died of hyperinfection syndrome, missed by the treating 139 
physicians. An alternative route of infection, in contrast to the common presentation of 140 
strongyloidiasis, could explain the shorter pre-patent period shown in these cases. 141 
Interestingly, recipient 2 presented with alveolar hemorrhage and bilateral lung 142 
infiltrates shortly after transplantation, rapidly improving after adding ivermectin and 143 
albendazole. This suggests the development of an acute hyperinfection syndrome. 144 
Unfortunately, we were unable to keep enough sample of bronchoalveolar lavage fluid for 145 
RT-PCR, which may have provided a definite diagnosis. In contrast, recipient 1 did not have 146 
symptoms attributable to strongyloidiasis prior to ivermectin treatment. Possible reasons 147 
for this are a higher larvae burden in the heart recipient due to contiguity in the surgical 148 




field and that recipient 2 had previously received high dose steroids for myocarditis 149 
treatment. 150 
Both recipients had negative stool microscopy and serology, which occurs in acute 151 
infections and illustrates the challenges that clinicians face with S. stercoralis diagnosis in 152 
immunosuppressed individuals. Apart from the low sensitivity of direct fecal examination, 153 
serological tests may provide a false negative result in acute cases, especially in 154 
immunocompromised patients.6 The possibility of intermittent low larvae output, especially 155 
in acute phases of infection, adds more complexity to diagnostic efforts.  156 
Although RT-PCR in stool is still under development, some studies have shown high 157 
sensitivity and specificity in S. stercoralis diagnosis.7, 9 However, this method may lose power 158 
if low larvae output,10 which can be overcome by stool concentration, as illustrated by 159 
Saugar and colleagues.8 Despite the need of further validation of RT-PCR for S. strongyloides 160 
detection, our report suggests that this technique could reduce the time to diagnosis and 161 
increase the diagnostic yield in possible donor-to-recipient transmissions. 162 
The American Society of Transplantation recommends screening S. stercoralis in 163 
donors and candidate recipients from endemic areas and/or with unexplained 164 
eosinophilia.11 However, these guidelines are often not followed by physicians worldwide, 165 
although a rapid detection can prompt antiparasitic treatment and decrease the risk of 166 
severe strongyloidiasis. A recent publication including data from the New York Organ Donor 167 
Network showed that among 233 eligible potential donors screened for S. stercoralis, 10 168 
(4.3%) had a positive serological result. Of note, no cases of infection occurred among those 169 
recipients who received an organ from infected donors, after receiving prophylaxis.12 170 




Transplant teams should be aware that strongyloidiasis is widely distributed in 171 
tropical and subtropical areas worldwide13, with higher transmission in regions with poorer 172 
socioeconomic conditions. Migrants from these regions are expected to present high 173 
infection rates such as in Southeast Asia, where prevalence rates of up to 50% in the general 174 
population may be present14.  175 
In summary, full implementation of current guidelines regarding S. stercoralis 176 
screening among donors is urgently required to avoid the occurrence of hyperinfection 177 
syndrome in SOT recipients. RT-PCR can be an effective diagnostic tool for an early 178 
detection of transmission among SOT recipients, facilitating a rapid initiation of antiparasitic 179 
treatment. 180 
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Figure 1. Chest X-ray showing bilateral alveolo-interstitial infiltrates in Recipient 2, on day 4 241 
post-transplant. 242 
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Solid organ transplant recipients can acquire Strongyloides stercoralis from an 26 
infected donor. The diagnosis of S. stercoralis in immunocompromised individuals may be 27 
challenging due to a lower sensitivity of available parasitological and serological methods, 28 
compared to immunocompetent individuals. Recently, a real-time polymerase chain 29 
reaction (RT-PCR) in stool has been developed for S. stercoralis diagnosis. We report two 30 
cases of S. stercoralis infection transmitted by a donor to two solid organ transplant 31 
recipients, who were diagnosed with real-time polymerase chain reactionRT-PCR in stool. 32 
This test could play a role in S. stercoralis diagnosis in immunosuppressed patients, 33 
facilitating rapid treatment initiation and reducing the risk of severe strongyloidiasis. 34 
Adherence to current recommendations of screening among donors and recipients from 35 
endemic areas is also urgently needed. 36 





Strongyloides stercoralis causes an opportunistic infection among 38 
immunosuppressed individuals. Chronically infected recipients of solid organ transplants 39 
(SOT) from endemic areas have an increased risk of severe strongyloidiasis, due to their 40 
immunosuppressed status.1 In recent years, some authors have reported the transmission 41 
of S. stercoralis from infected donors to recipients.2-5 Interestingly, most cases were 42 
diagnosed when recipients presented with hyperinfection syndrome and donors were found 43 
to have S. stercoralis on retrospective testing. 44 
Routine diagnosis of S. stercoralis is based on parasitological methods and serology, 45 
although their performance is far from optimal.6 Real-time polymerase chain reaction (RT-46 
PCR) has emerged as a promising diagnostic tool for S. stercoralis.7 Little is known about its 47 
potential role in subjects with a depressed cellular immune response, such as SOT 48 
recipients. 49 
We describe the usefulness and potential role of RT-PCR for the diagnosis of S. 50 
stercoralis in immunosuppressed individuals. This technique was used to detect the 51 
transmission of the parasite from an infected donor to two SOT recipients.  52 




Case report 53 
Donor 54 
A 45-year-old female patient from Paraguay was admitted to a Spanish hospital with 55 
one-month history of dyspnea, dry cough and fever. The patient had a previous diagnosis of 56 
systemic lupus erythematosus with nephropathy and she was under chronic therapy with 57 
steroids and mycophenolate mofetil. Upon admission, a chest x-ray showed bilateral 58 
alveolo-interstitial infiltrates and her blood tests revealed an acute renal failure and a non-59 
hemolytic anemia. 60 
On suspicion of a lupus flare the patient received a 500 mg methylprednisolone 61 
bolus. The patient’s respiratory condition progressively worsened, requiring admission to 62 
the intensive care unit. Piperacillin-tazobactam, levofloxacin and trimetoprim-63 
sulfametoxazol were added. Shortly after, hemoptysis developed with acute respiratory 64 
failure, prompting intubation and bronchoscopy which showed active bleeding in the left 65 
lung. An angio-CT revealed extensive peribronchovascular infiltrates suggestive of alveolar 66 
hemorrhage without malformations of bronchial arteries. An endovascular embolization of a 67 
left bronchial artery branch was performed. 68 
The patient was then treated with methylprednisolone, rituximab, mycophenolate 69 
mofetil and 4 days of immunoglobulins without clinical improvement. Broad-spectrum 70 
antibiotics were maintained. Ten days after admission, the patient developed a sudden 71 
hypertensive emergency associated with coma and non-reactive bradycardia. A brain CT 72 
revealed bilateral intracerebral hemorrhage and the patient finally died after evolving to 73 
brain death.  74 




The family consented for organ procurement and heart and liver were extracted for 75 
transplantation. Since the donor had lived in an endemic area, S. stercoralis serology was 76 
then performed using the commercial serological test IVD-ELISA (IVD Research, Carlsbad, 77 
CA), which detects IgG antibodies by using somatic antigens from S. stercoralis larvae. A 78 
positive result (i = 4.49 U/µL) was received on day 9 post-transplant. Transplant teams and 79 
organ procurement organizations were alerted.  80 
Recipient 1 81 
A 66-year old female patient with end-stage hepatic cirrhosis by hepatitis C virus 82 
infection underwent orthotopic liver transplantation. She was born and had lived in Spain 83 
during all her life. Immunosuppressive therapy was initiated with basiliximab, 84 
methylprednisolone and mycophenolate mofetil.  85 
On day 9, after receiving the positive result of S. stercoralis serology from the donor, 86 
ivermectin was empirically initiated at a dose of 200 µg/kg/day. Two stool samples were 87 
collected, but no larvae were found after direct examination. S. stercoralis serology was 88 
negative (i = 0.035 U/µl). The patient received 14 days of ivermectin and stools were 89 
monitored for larvae, which were not found on direct examination. 90 
The patient followed a severe clinical course, presenting multiple complications ten 91 
days after ending ivermectin. She was diagnosed with acute hepatitis by type 1 and 2 herpes 92 
viruses and abdominal septic shock, requiring treatment with vasopressors. She was treated 93 
with acyclovir, meropenem and vancomycin, but finally needed intravenous colistin due to 94 
multiresistant Pseudomonas aeruginosa bacteremia and bilateral pneumonia. The patient 95 
developed multiorgan failure, despite all treatment efforts, and died on day 34 post-96 
transplant. 97 




Stool samples collected prior to ivermectin initiation were sent to the National 98 
Centre for Microbiology (CNM-ISCIII), where RT-PCR for S. stercoralis was performed using 99 
the pair of primers designed from S. stercoralis 18S rRNA gene sequence.7 The amplification 100 
of the extracted DNA from previously concentrated stool samples is carried out according to 101 
the protocol described by Saugar et al.8 This test resulted positive. 102 
Recipient 2 103 
A 56-year old male patient was diagnosed with acute myocarditis and eventually 104 
cardiogenic shock that needed mechanical circulatory support with extracorporeal 105 
membrane oxygenation. Endomyocardial biopsy only showed fibrosis but with no 106 
myocardial cells. During the next month his condition did not improve and he was 107 
considered for orthotopic cardiac transplantation. He was born and had lived in Spain during 108 
all his life. After transplantation, he was initiated on immunosuppressive therapy with 109 
steroids, basiliximab, tacrolimus and mycophenolate mofetil. Pathological analysis of the 110 
recipient’s heart showed giant-cell myocarditis. 111 
On day 4 post-transplant, although he had normal cardiac and renal function, he 112 
presented with acute respiratory insufficiency requiring non-invasive mechanical 113 
ventilation. A chest x-ray revealed bilateral alveolo-interstitial infiltrates (Figure 1). Empirical 114 
antibiotic therapy with meropenem, linezolid and trimetoprim-sulfametoxazol was initiated 115 
and mycophenolate mofetil was discontinued. The patient underwent a bronchoscopy with 116 
bronchoalveolar lavage showing alveolar hemorrhage. 117 
All microbiological examinations in blood and bronchoalveolar lavage fluid were 118 
negative for bacteria, virus and fungi. Upon knowledge of donor’s positive S. stercoralis 119 
serology, on day 9 post-transplant, empirical oral treatment with ivermectin 200 µg/kg/day 120 




and albendazole 400 mg/12h was initiated and the dose of tacrolimus and steroids was 121 
decreased. The patient’s symptoms improved rapidly until complete resolution with 122 
radiologic disappearance of infiltrates. Treatment continued for 3 weeks and 123 
immunosuppressive drugs were reintroduced gradually. Two stool samples were negative 124 
for larvae on direct examination and the serology was non-reactive. The patient was finally 125 
discharged. Stool samples collected prior to ivermectin initiation were sent to CNM-ISCIII 126 
and RT-PCR tested positive for S. stercoralis. 127 





Our findings stress the importance of S. stercoralis screening among donors from 129 
endemic areas. It also highlights that RT-PCR in stools can provide an early diagnosis in those 130 
individuals receiving SOT from infected donors, prompting an early treatment and 131 
preventing the development of hyperinfection syndrome. 132 
This case adds to the existing reports of S. stercoralis transmission from donors to 133 
SOT recipients,2-5 but there are some important differences in our case. All donor-to-134 
recipients transmissions described so far were investigated when at least one SOT recipient 135 
presented with severe strongyloidiasis. Most cases were diagnosed 2-3 months after 136 
transplantation,2 probably after a sufficient period of immunosuppressive therapy. 137 
However, in our case, the donor was diagnosed post-mortem with a positive serology, which 138 
prompted investigations and empirical treatment of SOT recipients. One could even 139 
hypothesize that the donor died of hyperinfection syndrome, missed by the treating 140 
physicians. An alternative route of infection, in contrast to the common presentation of 141 
strongyloidiasis, could explain the shorter pre-patent period shown in these cases. 142 
Interestingly, recipient 2 presented with alveolar hemorrhage and bilateral lung 143 
infiltrates shortly after transplantation, rapidly improving after adding ivermectin and 144 
albendazole. This suggests the development of an acute hyperinfection syndrome. 145 
Unfortunately, we were unable to keep enough sample of bronchoalveolar lavage fluid for 146 
RT-PCR, which may have provided a definite diagnosis. In contrast, recipient 1 did not have 147 
symptoms attributable to strongyloidiasis prior to ivermectin treatment. Possible reasons 148 
for this are a higher larvae burden in the heart recipient due to contiguity in the surgical 149 




field and that recipient 2 had previously received high dose steroids for myocarditis 150 
treatment. 151 
Both recipients had negative stool microscopy and serology, which occurs in acute 152 
infections and illustrates the challenges that clinicians face with S. stercoralis diagnosis in 153 
immunosuppressed individuals. Apart from the low sensitivity of direct fecal examination, 154 
serological tests may provide a false negative result in acute cases, especially in 155 
immunocompromised patients.6 The possibility of intermittent low larvae output, especially 156 
in acute phases of infection, adds more complexity to diagnostic efforts.  157 
Although RT-PCR in stool is still under development, some studies have shown high 158 
sensitivity and specificity in S. stercoralis diagnosis.7, 9 However, this method may lose power 159 
if low larvae output,10 which can be overcome by stool concentration, as illustrated by 160 
Saugar and colleagues.8 Despite the need of further validation of RT-PCR for S. strongyloides 161 
detection, our report suggests that this technique could reduce the time to diagnosis and 162 
increase the diagnostic yield in possible donor-to-recipient transmissions. 163 
The American Society of Transplantation recommends screening S. stercoralis in 164 
donors and candidate recipients from endemic areas and/or with unexplained 165 
eosinophilia.11 However, these guidelines are often not followed by physicians worldwide, 166 
although a rapid detection can prompt antiparasitic treatment and decrease the risk of 167 
severe strongyloidiasis. A recent publication including data from the New York Organ Donor 168 
Network showed that among 233 eligible potential donors screened for S. stercoralis, 10 169 
(4.3%) had a positive serological result. Of note, no cases of infection occurred among those 170 
recipients who received an organ from infected donors, after receiving prophylaxis.12 171 




Transplant teams should be aware that strongyloidiasis is widely distributed in 172 
tropical and subtropical areas worldwide13, with higher transmission in regions with poorer 173 
socioeconomic conditions. Migrants from these regions are expected to present high 174 
infection rates such as in Southeast Asia, where prevalence rates of up to 50% in the general 175 
population may be present14.  176 
In summary, full implementation of current guidelines regarding S. stercoralis 177 
screening among donors is urgently required to avoid the occurrence of hyperinfection 178 
syndrome in SOT recipients. RT-PCR can be an effective diagnostic tool for an early 179 
detection of transmission among SOT recipients, facilitating a rapid initiation of antiparasitic 180 
treatment. 181 
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Figure 1. Chest X-ray showing bilateral alveolo-interstitial infiltrates in Recipient 2, on day 4 242 
post-transplant. 243 
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